Literature DB >> 17255260

Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray.

Toshiaki Watanabe1, Takashi Kobunai, Etsuko Toda, Takamitsu Kanazawa, Yoshihiro Kazama, Junichiro Tanaka, Toshiaki Tanaka, Yoko Yamamoto, Keisuke Hata, Tetsu Kojima, Tadashi Yokoyama, Tsuyoshi Konishi, Yoshihiro Okayama, Yoshikazu Sugimoto, Toshinori Oka, Shin Sasaki, Yohichi Ajioka, Tetsuichiro Muto, Hirokazu Nagawa.   

Abstract

PURPOSE: Ulcerative colitis (UC) is associated with a high risk of colorectal cancer. To identify genes that could predict the development of cancer in UC, we conducted a DNA microarray analysis using nonneoplastic rectal mucosa of UC patients. EXPERIMENTAL
DESIGN: Gene expression in nonneoplastic mucosa of 53 UC patients were examined. Gene expression profiles were examined using human Genome U133 Plus 2.0 gene chip array (Affymetrix). Among 53 UC patients, 10 had UC-associated cancer (UC-Ca group) whereas 43 did not (UC-NonCa group).
RESULTS: By comparing gene expression profiles of nonneoplastic rectal mucosae between the UC-Ca and UC-NonCa groups, we could identify 40 genes that were differentially expressed between two groups. The list of discriminating genes included low-density lipoprotein receptor-related protein (LRP5 and LRP6). Previous studies suggested that LRP5 and LRP6 expression promotes cancer cell proliferation and tumorigenesis and are considered as candidate oncogenes. In the present study, both LRP5 and LRP6 showed significantly higher expression in the UC-Ca group, which suggests the importance of these genes in the development of UC-associated colorectal cancers. With the 40 selected discriminating genes, we did class prediction of the development of colorectal neoplasms in UC patients. Using the k-nearest neighbor method and the support vector machine, we could predict the development of UC-associated neoplasms with an accuracy of 86.8% and 98.1%, respectively.
CONCLUSIONS: These findings have important implications for the early detection of malignant lesions in UC and may provide directions for future research into the molecular mechanisms of UC-associated cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17255260     DOI: 10.1158/1078-0432.CCR-06-0753

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  21 in total

1.  Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer.

Authors:  Junjie Peng; Zhimin Wang; Wei Chen; Yin Ding; Haifeng Wang; Hongjie Huang; Wei Huang; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2010-08-13       Impact factor: 2.571

2.  Lrp5 and Lrp6 play compensatory roles in mouse intestinal development.

Authors:  Zhendong Zhong; Jacob J Baker; Cassandra R Zylstra-Diegel; Bart O Williams
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

3.  Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia.

Authors:  Rajan K Bista; Teresa A Brentnall; Mary P Bronner; Christopher J Langmead; Randall E Brand; Yang Liu
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

4.  Gene expression profiles in peripheral blood mononuclear cells of ulcerative colitis patients.

Authors:  Ying-Lei Miao; Yu-Liang Xiao; Yan Du; Li-Ping Duan
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

5.  Expression of Oncogenic Molecules in Pediatric Ulcerative Colitis.

Authors:  Nobuyasu Arai; Takahiro Kudo; Kazuhide Tokita; Reiko Kyodo; Masamichi Sato; Eri Miyata; Kenji Hosoi; Tamaki Ikuse; Keisuke Jimbo; Yoshikazu Ohtsuka; Toshiaki Shimizu
Journal:  Digestion       Date:  2021-10-29       Impact factor: 3.216

6.  Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.

Authors:  Joel Pekow; Urszula Dougherty; Yong Huang; Edward Gometz; Jeff Nathanson; Greg Cohen; Shawn Levy; Masha Kocherginsky; Nanda Venu; Maria Westerhoff; John Hart; Amy E Noffsinger; Stephen B Hanauer; Roger D Hurst; Alessandro Fichera; Loren J Joseph; Qiang Liu; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

7.  CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer.

Authors:  Hiromi Yasuda; Koji Tanaka; Yoshiki Okita; Toshimitsu Araki; Susumu Saigusa; Yuji Toiyama; Takeshi Yokoe; Shigeyuki Yoshiyama; Aya Kawamoto; Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  Oncol Lett       Date:  2011-09-06       Impact factor: 2.967

8.  A gene signature for post-infectious chronic fatigue syndrome.

Authors:  John W Gow; Suzanne Hagan; Pawel Herzyk; Celia Cannon; Peter O Behan; Abhijit Chaudhuri
Journal:  BMC Med Genomics       Date:  2009-06-25       Impact factor: 3.063

9.  Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells.

Authors:  Wendy S Garrett; Shivesh Punit; Carey A Gallini; Monia Michaud; Dorothy Zhang; Kirsten S Sigrist; Graham M Lord; Jonathan N Glickman; Laurie H Glimcher
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

10.  Surgical procedure for sporadic colorectal cancer in patients with mild ulcerative colitis.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Hiroki Matsuoka; Toshihiro Bando; Akihiro Hirata; Satoru Yasukawa; Yoshio Takesue; Naohiro Tomita
Journal:  Case Rep Gastroenterol       Date:  2012-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.